home / stock / pnexf / pnexf short
Short Information | Pharnext SA (OTCMKTS:PNEXF)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 37,213 |
Total Actual Volume | 17,819 |
Short Trends | |
---|---|
Cover Days | 1 |
Short Days | 19 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 1,861 |
Average Short Percentage | 590.13% |
Is there a PNEXF Short Squeeze or Breakout about to happen?
See the PNEXF Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
10-07-2021 | $0.5 | $0.5 | $0.5 | $0.5 | 5,000 | 5,000 | 100% |
06-24-2021 | $1.7 | $1.7 | $1.7 | $1.7 | 200 | 20,000 | 10000% |
03-10-2021 | $4.11 | $4.11 | $4.11 | $4.11 | 1,000 | 1,000 | 100% |
01-19-2021 | $4.29 | $4.29 | $4.29 | $4.29 | 735 | 735 | 100% |
12-31-2020 | $4.25 | $4.25 | $4.25 | $4.25 | 5,000 | 5,000 | 100% |
09-25-2020 | $3.65 | $3.65 | $3.65 | $3.65 | 400 | 400 | 100% |
07-08-2020 | $3.92 | $3.92 | $3.92 | $3.92 | 1,000 | 1,000 | 100% |
05-26-2020 | $3.59 | $3.59 | $3.59 | $3.59 | 469 | 469 | 100% |
02-11-2020 | $6.95 | $6.95 | $6.95 | $6.95 | 150 | 150 | 100% |
01-17-2020 | $6.50 | $6.50 | $6.50 | $6.50 | 150 | 150 | 100% |
01-15-2020 | $6.69 | $6.69 | $6.69 | $6.69 | 500 | 500 | 100% |
01-13-2020 | $6.85 | $6.85 | $6.85 | $6.85 | 1,000 | 1,000 | 100% |
11-26-2019 | $N/A | $5.15 | $N/A | $N/A | 417 | 11 | 2.64% |
09-23-2019 | $6.27 | $6.27 | $6.27 | $6.27 | 100 | 100 | 100% |
08-19-2019 | $13.00 | $13.00 | $13.00 | $13.00 | 100 | 100 | 100% |
08-14-2019 | $N/A | $11.20 | $N/A | $N/A | 82 | 82 | 100% |
07-24-2019 | $N/A | $13.80 | $N/A | $N/A | 15 | 15 | 100% |
06-10-2019 | $15.40 | $15.40 | $15.40 | $15.40 | 400 | 400 | 100% |
05-23-2019 | $15.39 | $15.39 | $15.39 | $15.39 | 100 | 100 | 100% |
05-14-2019 | $19.30 | $19.30 | $19.30 | $19.30 | 1,001 | 1,001 | 100% |
News, Short Squeeze, Breakout and More Instantly...
Pharnext SA Company Name:
PNEXF Stock Symbol:
OTCMKTS Market:
PARIS, FRANCE / ACCESSWIRE / January 4, 2023 / Pharnext SA (FR001400BV89:ALPHA) (the "Company"), an advanced late-clinical stage biopharmaceutical company developing novel therapeutics for neurodegenerative diseases with high unmet medical need, today announces the appointment of Scott Johnson a...
PARIS, FRANCE / ACCESSWIRE / March 31, 2021 / Pharnext SA (FR0011191287 - ALPHA) (the 'Company'), an advanced late-stage clinical biopharmaceutical company pioneering new approaches to developing innovative drug combinations based on big genomics data and artificial intelligence using its PL...
€6 million capital raise priced at market with warrants subscribed by two existing shareholders, €5 million convertible bonds issued to European investors, European investors have also provided written indication of strong interest for the potential of additional ...